The use of bacteria and bacterial extracts for immunotherapy has a checkered past. Recent
developments in immunology reveal that these nonspecific immune activators actually work
by triggering specific receptors that are expressed by subsets of immune cells. Identification
of these receptors and the molecular signaling pathways that they activate has enabled a
new era of specific targeted immunotherapy using chemically synthesized mimics of
pathogen molecules.